Treffer 1 - 3 von 3 für Suche 'Wendekier, Katy', Suchdauer: 0,32s Treffer weiter einschränken
  1. 1
    Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple‐negative breast cancer

    Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple‐negative breast cancer von Wright, Thomas D., Raybuck, Christopher, Bhatt, Akshita, Monlish, Darlene, Chakrabarty, Suravi, Wendekier, Katy, Gartland, Nathan, Gupta, Mohit, Burow, Matthew E., Flaherty, Patrick T., Cavanaugh, Jane E.


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer

    Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer von Wright, Thomas D, Raybuck, Christopher, Bhatt, Akshita, Monlish, Darlene, Chakrabarty, Suravi, Wendekier, Katy, Gartland, Nathan, Gupta, Mohit, Burow, Matthew E, Flaherty, Patrick T, Cavanaugh, Jane E


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Abstract 2392: Evaluation of synergistic PI3K/Akt and MEK5/ERK5 inhibition in triple-negative breast cancer

    Abstract 2392: Evaluation of synergistic PI3K/Akt and MEK5/ERK5 inhibition in triple-negative breast cancer von Wright, Thomas D., Raybuck, Christopher, Gartland, Nathan, Wendekier, Katy, Monlish, Darlene, Chakrabarty, Suravi, Flaherty, Patrick T., Burow, Matthew E., Cavanaugh, Jane E.

    Veröffentlicht in Cancer research (Chicago, Ill.)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: